Amy Gillespie

981 total citations
21 papers, 517 citations indexed

About

Amy Gillespie is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Amy Gillespie has authored 21 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 4 papers in Pharmacology and 4 papers in Clinical Psychology. Recurrent topics in Amy Gillespie's work include Schizophrenia research and treatment (8 papers), Stress Responses and Cortisol (3 papers) and Epigenetics and DNA Methylation (3 papers). Amy Gillespie is often cited by papers focused on Schizophrenia research and treatment (8 papers), Stress Responses and Cortisol (3 papers) and Epigenetics and DNA Methylation (3 papers). Amy Gillespie collaborates with scholars based in United Kingdom, China and United States. Amy Gillespie's co-authors include James H. MacCabe, Alice Egerton, Jonathan Mill, Runsen Chen, Grant McQueen, Kyra-Verena Sendt, Catherine J. Harmer, Susannah E. Murphy, Yingjun Xi and Philip J. Cowen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biological Psychiatry and Psychological Medicine.

In The Last Decade

Amy Gillespie

19 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Gillespie United Kingdom 11 225 143 98 87 86 21 517
Qiufang Jia China 15 155 0.7× 134 0.9× 103 1.1× 94 1.1× 108 1.3× 31 580
Kyra-Verena Sendt United Kingdom 11 321 1.4× 165 1.2× 123 1.3× 54 0.6× 91 1.1× 18 614
Ali Bani‐Fatemi Canada 13 141 0.6× 193 1.3× 117 1.2× 57 0.7× 53 0.6× 51 474
Melissa Kerr Australia 12 266 1.2× 167 1.2× 62 0.6× 56 0.6× 84 1.0× 24 488
Berna Uluğ Türkiye 12 163 0.7× 190 1.3× 151 1.5× 113 1.3× 46 0.5× 23 574
Yasuya Nakato Japan 11 105 0.5× 149 1.0× 57 0.6× 52 0.6× 40 0.5× 17 420
Daniel Guinart United States 16 352 1.6× 180 1.3× 65 0.7× 72 0.8× 43 0.5× 42 724
Floortje E. Scheepers Netherlands 11 181 0.8× 152 1.1× 195 2.0× 106 1.2× 31 0.4× 29 568
Danielle L. Taylor United States 10 262 1.2× 170 1.2× 153 1.6× 63 0.7× 41 0.5× 33 585
Peixian Mao China 11 189 0.8× 78 0.5× 59 0.6× 68 0.8× 29 0.3× 22 421

Countries citing papers authored by Amy Gillespie

Since Specialization
Citations

This map shows the geographic impact of Amy Gillespie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Gillespie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Gillespie more than expected).

Fields of papers citing papers by Amy Gillespie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Gillespie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Gillespie. The network helps show where Amy Gillespie may publish in the future.

Co-authorship network of co-authors of Amy Gillespie

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Gillespie. A scholar is included among the top collaborators of Amy Gillespie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Gillespie. Amy Gillespie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zelaya, Fernando, Kyra-Verena Sendt, Grant McQueen, et al.. (2024). Response to clozapine in treatment resistant schizophrenia is related to alterations in regional cerebral blood flow. SHILAP Revista de lepidopterología. 10(1). 122–122.
2.
Gillespie, Amy, Emma Walker, Eilís Hannon, et al.. (2024). Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts. Translational Psychiatry. 14(1). 390–390. 3 indexed citations
3.
Chung, Raymond T., John Lally, Grant McQueen, et al.. (2023). Changes in immunoglobulin levels during clozapine treatment in schizophrenia. Brain Behavior and Immunity. 115. 223–228. 10 indexed citations
4.
5.
6.
McQueen, Grant, Kyra-Verena Sendt, Amy Gillespie, et al.. (2022). Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia. SHILAP Revista de lepidopterología. 8(1). 13–13. 9 indexed citations
7.
Chapman, Sarah, et al.. (2022). Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research. Translational Psychiatry. 12(1). 484–484. 28 indexed citations
8.
Carson, James Taylor, et al.. (2021). Online behavioural activation during the COVID-19 pandemic decreases depression and negative affective bias. Psychological Medicine. 53(3). 795–804. 6 indexed citations
9.
Murphy, Susannah E., Angharad N. de Cates, Amy Gillespie, et al.. (2020). Translating the promise of 5HT4 receptor agonists for the treatment of depression. Psychological Medicine. 51(7). 1111–1120. 31 indexed citations
10.
11.
Gillespie, Amy, et al.. (2020). P.737 Risk factors for depression vulnerability during the COVID-19 pandemic: findings from the Oxford COSIE (COVID-19, Social Isolation and Emotion) Study. European Neuropsychopharmacology. 40. S417–S418. 2 indexed citations
12.
McQueen, Grant, Kyra-Verena Sendt, Amy Gillespie, et al.. (2020). Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant Schizophrenia. Schizophrenia Bulletin. 47(3). 662–671. 45 indexed citations
13.
Xi, Yingjun, Runsen Chen, Amy Gillespie, et al.. (2019). Mental health workers perceptions of disaster response in China. BMC Public Health. 19(1). 11–11. 14 indexed citations
14.
Peng, Ke, Xuequan Zhu, Amy Gillespie, et al.. (2019). Self-reported Rates of Abuse, Neglect, and Bullying Experienced by Transgender and Gender-Nonbinary Adolescents in China. JAMA Network Open. 2(9). e1911058–e1911058. 72 indexed citations
15.
Liu, Yan, Xiaojie Yang, Amy Gillespie, et al.. (2018). Targeting relapse prevention and positive symptom in first-episode schizophrenia using brief cognitive behavioral therapy: A pilot randomized controlled study. Psychiatry Research. 272. 275–283. 15 indexed citations
16.
17.
Kravariti, Eugenia, Amy Gillespie, Kelly Diederen, et al.. (2018). Applying the Higher Education Academy Framework for Partnership in Learning and Teaching in Higher Education to Online Partnership Learning Communities: A Case Study and an Extended Model. Teaching & Learning Inquiry The ISSOTL Journal. 6(2). 143–164. 2 indexed citations
18.
Gillespie, Amy, et al.. (2018). Biological Predictors of Clozapine Response: A Systematic Review. Frontiers in Psychiatry. 9. 327–327. 45 indexed citations
19.
Gillespie, Amy, Eilís Hannon, Emma Dempster, et al.. (2017). Longitudinal Epigenetic Analysis Of Clozapine Use In Treatment-Resistant Schizophrenia: Data From The Crestar Consortium. European Neuropsychopharmacology. 27. S463–S464. 1 indexed citations
20.
Gillespie, Amy, et al.. (2017). Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review. BMC Psychiatry. 17(1). 12–12. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qiufang Jia Breakdown of academic impact, for papers by Kyra-Verena Sendt Breakdown of academic impact, for papers by Ali Bani‐Fatemi Breakdown of academic impact, for papers by Melissa Kerr Breakdown of academic impact, for papers by Berna Uluğ Breakdown of academic impact, for papers by Yasuya Nakato Breakdown of academic impact, for papers by Daniel Guinart Breakdown of academic impact, for papers by Floortje E. Scheepers Breakdown of academic impact, for papers by Danielle L. Taylor Breakdown of academic impact, for papers by Peixian Mao
Rankless by CCL
2026